L-Carn

Levocarnitine, the active ingredient in L-Carn, is a nutritional supplement presented as an oral formulation for oral use. It is used to treat primary or secondary carnitine deficiency and to support fatty‑acid metabolism in patients with mitochondrial or metabolic disorders. The compound facilitates transport of long‑chain fatty acids into mitochondria, enhancing cellular energy production.

GNH USA supplies L-Carn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery and regulatory compliance across multiple regions.

L‑Carn (levocarnitine) is employed to address disorders of fatty‑acid metabolism and carnitine deficiency. - Carnitine deficiency: restores normal cellular carnitine levels and improves energy production. - Fatty acid metabolism disorders: enhances beta‑oxidation of long‑chain fatty acids, supporting metabolic stability. - Mitochondrial disorders: assists mitochondrial function by facilitating fatty‑acid transport, helping reduce fatigue and muscle weakness. - Secondary carnitine depletion: helps replenish carnitine stores during dialysis or certain medications.

Levocarnitine may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Nausea - Vomiting - Abdominal cramps - Diarrhea - Fishy body odor

Serious or Rare Side Effects: - Muscle weakness or myopathy - Seizures - Cardiac arrhythmia - Severe allergic reactions (e.g., anaphylaxis) - Liver function abnormalities

When using levocarnitine, several precautionary measures should be observed to ensure safety. - Renal function assessment: evaluate kidney status before initiating therapy, especially in patients with chronic kidney disease. - Gastrointestinal monitoring: watch for persistent nausea, vomiting or diarrhea and adjust dosage if needed. - Metabolic disorder evaluation: confirm diagnosis of carnitine deficiency or related metabolic condition prior to use. - Seizure risk awareness: use cautiously in individuals with a history of seizures or epilepsy. - Hypersensitivity check: discontinue if signs of allergic reaction such as rash, itching or swelling appear. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Levocarnitine can interact with certain medicines, affecting their efficacy or safety.

Major Interactions (Avoid): - Warfarin: levocarnitine may enhance anticoagulant effect, increasing bleeding risk. - Valproic acid: may reduce plasma carnitine levels, diminishing therapeutic benefit. - Carbapenem antibiotics (e.g., imipenem): can decrease carnitine absorption, leading to deficiency.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: levocarnitine may alter hormone metabolism; monitor thyroid function tests. - Diuretics (especially thiazides): may increase urinary carnitine loss; assess carnitine status periodically. - Anticonvulsants (e.g., phenobarbital): potential for altered carnitine levels; observe seizure control.